Maria Concetta Geloso

Prof. Maria Concetta Geloso

Department of Neuroscience-Section of Human Anatomy,Università Cattolica del Sacro Cuore, Milan, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2017 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
MGMaria Concetta Geloso
Maria Concetta Geloso
VCValentina Corvino
Valentina Corvino
EMElisa Marchese
Elisa Marchese
ASAlessia Serrano
Alessia Serrano
FMFabrizio Michetti
Fabrizio Michetti
NDNadia D’aMbrosi
Nadia D’aMbrosi
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a non-cell autonomous motor neuron loss. While it is generally believed that the disease onset takes place inside motor neurons, different cell types mediating neuroinflammatory processes are considered deeply involved in the progression of the disease. On these grounds, many treatments have been tested on ALS animals with the aim of inhibiting or reducing the pro-inflammatory action of microglia and astrocytes and counteract the progression of the disease. Unfortunately, these anti-inflammatory therapies have been only modestly successful. The non-univocal role played by microglia during stress and injuries might explain this failure. Indeed, it is now well recognized that, during ALS, microglia displays different phenotypes, from surveillant in early stages, to activated states, M1 and M2, characterized by the expression of respectively harmful and protective genes in later phases of the disease. Consistently, the inhibition of microglial function seems to be a valid strategy only if the different stages of microglia polarization are taken into account, interfering with the reactivity of microglia specifically targeting only the harmful pathways and/or potentiating the trophic ones. In this review, we will analyze the features and timing of microglia activation in the light of M1/M2 phenotypes in the main mice models of ALS. Moreover, we will also revise the results obtained by different anti-inflammatory therapies aimed to unbalance the M1/M2 ratio, shifting it towards a protective outcome.

20 March 2021 in Cells
Verified
Journal Article
Open access
PDF file
MGMaria Concetta Geloso
Maria Concetta Geloso
Nadia D'AmbrosiNadia D'Ambrosi
Nadia D'Ambrosi
Microglia, besides being able to react rapidly to a wide range of environmental changes, are also involved in shaping neuronal wiring. Indeed, they actively participate in the modulation of neuronal function by regulating the elimination (or “pruning”) of weaker synapses in both physiologic and pathologic processes. Mounting evidence supports their crucial role in early synaptic loss, which is emerging as a hallmark of several neurodegenerative diseases, including multiple sclerosis (MS) and its preclinical models. MS is an inflammatory, immune-mediated pathology of the white matter in which demyelinating lesions may cause secondary neuronal death. Nevertheless, primitive grey matter (GM) damage is emerging as an important contributor to patients’ long-term disability, since it has been associated with early and progressive cognitive decline (CD), which seriously worsens the quality of life of MS patients. Widespread synapse loss even in the absence of demyelination, axon degeneration and neuronal death has been demonstrated in different GM structures, thus raising the possibility that synaptic dysfunction could be an early and possibly independent event in the neurodegenerative process associated with MS. This review provides an overview of microglial-dependent synapse elimination in the neuroinflammatory process that underlies MS and its experimental models.

1 January 2021 in Experimental Neurology
Verified
Journal Article
Closed access
EMElisa Marchese
Elisa Marchese
MVMariagrazia Valentini
Mariagrazia Valentini
Gabriele Di SanteGabriele Di Sante
Gabriele Di Sante
ECEleonora Cesari
Eleonora Cesari
AAAnnalisa Adinolfi
Annalisa Adinolfi
MGMaria Concetta Geloso
Maria Concetta Geloso

26 October 2018 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
EMElisa Marchese
Elisa Marchese
VCValentina Corvino
Valentina Corvino
VMValentina Di Maria
Valentina Di Maria
AFAlfredo Furno
Alfredo Furno
SGStefano Giannetti
Stefano Giannetti
MGMaria Concetta Geloso
Maria Concetta Geloso
Hippocampal dysfunction plays a central role in neurodevelopmental disorders, resulting in severe impairment of cognitive abilities, including memory and learning. On this basis, developmental studies represent an important tool both to understanding the cellular and molecular phenomena underlying early hippocampal damage and to study possible therapeutic interventions, that may modify the progression of neuronal death. Given the modulatory role played by 17β-estradiol (E2) on hippocampal functions and its neuroprotective properties, the present study investigates the effects of pretreatment with E2 in a model of neonatal hippocampal injury obtained by trimethyltin (TMT) administration, characterized by neuronal loss in CA1 and CA3 subfields and astroglial and microglial activation. At post-natal days (P)5 and P6 animals received E2 administration (0.2 mg/kg/die i.p.) or vehicle. At P7 they received a single dose of TMT (6.5 mg/kg i.p.) and were sacrificed 72 h (P10) or 7 days after TMT treatment (P14). Our findings indicate that pretreatment with E2 exerts a protective effect against hippocampal damage induced by TMT administration early in development, reducing the extent of neuronal death in the CA1 subfield, inducing the activation of genes involved in neuroprotection, lowering the neuroinflammatory response and restoring neuropeptide Y- and parvalbumin- expression, which is impaired in the early phases of TMT-induced damage. Our data support the efficacy of estrogen-based neuroprotective approaches to counteract early occurring hippocampal damage in the developing hippocampus.

4 April 2017 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
EMElisa Marchese
Elisa Marchese
VMValentina Di Maria
Valentina Di Maria
DSDaniela Samengo
Daniela Samengo
GPGiovambattista Pani
Giovambattista Pani
Fabrizio MichettiFabrizio Michetti
Fabrizio Michetti
MGMaria Concetta Geloso
Maria Concetta Geloso

12 January 2023 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
AAAnnalisa Adinolfi
Annalisa Adinolfi
GSGabriele Di Sante
Gabriele Di Sante
LVLuca Rivignani Vaccari
Luca Rivignani Vaccari
MTMaria Tredicine
Maria Tredicine
FRFrancesco Ria
Francesco Ria
MGMaria Concetta Geloso
Maria Concetta Geloso
Multiple sclerosis (MS) and its preclinical models are characterized by marked changes in neuroplasticity, including excitatory/inhibitory imbalance and synaptic dysfunction that are believed to underlie the progressive cognitive impairment (CI), which represents a significant clinical hallmark of the disease. In this study, we investigated several parameters of neuroplasticity in the hippocampus of the experimental autoimmune encephalomyelitis (EAE) SJL/J mouse model, characterized by rostral inflammatory and demyelinating lesions similar to Relapsing–Remitting MS. By combining morphological and molecular analyses, we found that the hippocampus undergoes extensive inflammation in EAE-mice, more pronounced in the CA3 and dentate gyrus (DG) subfields than in the CA1, associated with changes in GABAergic circuitry, as indicated by the increased expression of the interneuron marker Parvalbumin selectively in CA3. By laser-microdissection, we investigated the impact of EAE on the alternative splicing of Arhgef9, a gene encoding a post-synaptic protein playing an essential role in GABAergic synapses and whose mutations have been related to CI and epilepsy. Our results indicate that EAE induces a specific increase in inclusion of the alternative exon 11a only in the CA3 and DG subfields, in line with the higher local levels of inflammation. Consistently, we found a region-specific downregulation of Sam68, a splicing-factor that represses this splicing event. Collectively, our findings confirm a regionalized distribution of inflammation in the hippocampus of EAE-mice. Moreover, since neuronal circuit rearrangement and dynamic remodeling of structural components of the synapse are key processes that contribute to neuroplasticity, our study suggests potential new molecular players involved in EAE-induced hippocampal dysfunction.